Feng Yang: Focus on the process, not the result.
Release time:
2020-10-23
Feng Yang: Focus on the process and do not ask for results
Feng Yang is an old employee of the peak. From 2003 to now, it has been 17 years since he came to Jianfeng International Trade Company. He used to mainly do information, logistics and administrative work. Although 2019 3# September began to take over the company's chlor-alkali business, while busy with business work, he did not put down other work arranged by the company. For example, he completed the land bidding and delisting planning approval and license handling of the new warehouse project together with his colleagues. Of course, the main reason why he can be rated as an excellent salesman of the group company in 2019 is his achievements after taking over the chlor-alkali business.
8One day in April, the author came to Feng Yang's office at the appointed time. As soon as he saw Feng Yang, he gave the impression of being kind and approachable, and the office was very clean and tidy. Feng Yang poured the author a cup of tea and talked about his work experience last year.
Q:You used to work in logistics administration and took over the chlor-alkali business in 2019 . This is a shift from affairs to marketing-like work with such a large span. How did you get familiar with the situation quickly and get your work on the right track?
Answer:The span is indeed very large, but fortunately, I have participated in the operation of the e-commerce park before, and the content is somewhat related. I have accumulated a lot of valuable experience in it, which is a very important foundation. Although there is a certain connection, after all, there are still differences, and previous experience cannot be copied. When I just took over the business, my job role suddenly changed, and I was inevitably unfamiliar with the new job content. The competition in the warehousing industry was fierce, and the early pressure was still quite great.
Q:So how did you solve the problem later?
A:Actually, there are no special new tricks, they are all old and stupid methods. It is to rely on one step at a time to run more customers and make many trips a year. In this way, on the one hand, we are familiar with the original business, strengthen communication with old customers, and improve our service quality; on the other hand, we are constantly striving to develop new customers and new business. After long-term efforts, we have cooperated with leading enterprises in the chemical materials industry in the northwest region.
Q:As the saying goes, what achievements have been made after the difficulties have been solved?
A:In the past year, around the responsibility system target issued by the company, we have fulfilled our job responsibilities relatively well, and actively developed upstream customers such as Zhongtai in Xinjiang, Ordos and Beiyuan in Shaanxi. As a result, the arrival volume of PVC reached more than 7 tons that year, up more than 60% from the previous month, exceeding the tasks assigned by the company. Among them, container arrivals increased by more than 40%. The increase in the amount of arrival has brought about an increase in the amount of delivery and throughput, which has contributed to the completion of the Group's responsibility tasks.
Q:What is the deepest feeling about the work of 2019 ?
A:It's not easy to do business! (Laughter) But it's okay. While I'm young and in good health, I struggle more for my career. I enjoy it and enjoy it.
Q:Having achieved these results and being rated as the excellent marketer of the group company in the year 2019 , have you achieved your goals or expectations in your heart?
A:As for the achievements and honors, I actually don't think much about them, and I just focus on the process. To do every aspect of the process in a down-to-earth and down-to-earth manner is what I want to do. To achieve such results, it is inseparable from the cooperation, coordination and cooperation of all departments of the whole company, and the support and help of company leaders and colleagues. (Reporter Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31